Innovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
3 years agoInnovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
3 years ago
The Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
3 years agoThe Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
3 years ago
Real World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
3 years agoReal World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
3 years ago
Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
3 years agoPrecision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
3 years ago
The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
3 years agoThe Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
3 years ago
Optimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
3 years agoOptimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
3 years ago
Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
3 years agoInnovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
3 years ago
Emerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
3 years agoEmerging therapeutic areas of clinical attention & investment opportunities
Investment opportunities have changed substantially across the life sciences and pharmaceutical industry in the last ten years. It has become obvious that areas like neuroscience and respiratory medicine require additional support due to unmet clinical needs. Investment is key to...
3 years ago
Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
3 years agoEvaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
3 years ago
Weekly News Round-up – 9/4/21
In the news this week, Genmab suggests potential investment plans for spin-off biotechs. In other news, alternative COVID-19 vaccines offered to under-30s, and Acadia fails to achieve FDA approval for psychosis drug. GENMAB CEO HINTS AT FUTURE INVESTMENT PLANS –...
3 years agoWeekly News Round-up – 9/4/21
In the news this week, Genmab suggests potential investment plans for spin-off biotechs. In other news, alternative COVID-19 vaccines offered to under-30s, and Acadia fails to achieve FDA approval for psychosis drug. GENMAB CEO HINTS AT FUTURE INVESTMENT PLANS –...
3 years ago